
Featured
Oxford and CRISPR Therapeutics Achieve First Functional Cure for Type 1 Diabetes via In Vivo Gene Editing
Oxford University and CRISPR Therapeutics have achieved the first functional cure for Type 1 Diabetes in humans using in vivo CRISPR-Cas9 gene editing...
Read Full Story →
